Crescent Biopharma, Inc. (CBIO)
NASDAQ · Healthcare
Crescent Biopharma, Inc. Cash on Hand 2012–2025
Crescent Biopharma, Inc. annual cash on hand history from 2013 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Crescent Biopharma, Inc. cash on hand as of December 31, 2025: 213.2M, a 410.12% increase year-over-year.
- Crescent Biopharma, Inc. cash on hand for 2025 were 213.2M, a 410.12% increase from 2023.
- Crescent Biopharma, Inc. cash on hand for 2023 were 41.8M, a 12.70% decrease from 2022.
- Crescent Biopharma, Inc. cash on hand for 2022 were 47.9M, a 46.96% decrease from 2021.
- Crescent Biopharma, Inc. cash on hand for 2021 were 90.3M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Crescent Biopharma, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $213 |
| 2023 | $42 |
| 2022 | $48 |
| 2021 | $90 |
| 2020 | $137 |
| 2016 | $40 |
| 2015 | $47 |
| 2014 | $55 |
| 2013 | $2 |
Crescent Biopharma, Inc. Cash on Hand — FAQ
Crescent Biopharma, Inc. (CBIO) cash on hand over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CBIO's cash on hand history?
The chart and table above show Crescent Biopharma, Inc.'s cash on hand by year and by quarter, including the growth rate.